DeepMed Research

The University Of Texas Health Science Center At San Antonio

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Acceptance and Commitment Therapy for Chronic Pain in Integrated Primary Care

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: Focused Acceptance & Commitment Therapy (FACT)
Behavioral: Enhanced Treatment as Usual (ETAU)

First Posted Date: 2021-07-27

Last Posted Date: 2021-07-27

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 26

Registration Number: NCT04978961

Locations: 🇺🇸
Medical Drive Primary Care, San Antonio, Texas, United States

ALS and Airway Clearance (ALSAC) Therapy

Not Applicable

Completed

Conditions: Amyotrophic Lateral Sclerosis
Respiratory Muscle Weakness

Interventions: Device: High Frequency Chest Wall Oscillation
Device: Mechanical insufflation/exsufflation

First Posted Date: 2021-07-01

Last Posted Date: 2021-11-04

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 28

Registration Number: NCT04947436

Locations: 🇺🇸
University of Texas Health San Antonio, San Antonio, Texas, United States

Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

Phase 2

Active, not recruiting

Conditions: Cancer of the Head and Neck

Interventions: Drug: Dermaprazole
Drug: Aquaphor

First Posted Date: 2021-04-29

Last Posted Date: 2024-08-22

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 6

Registration Number: NCT04865731

Locations: 🇺🇸
Mays Cancer Center, San Antonio, Texas, United States

Contingency Management for Cannabis Use for Persons With HIV

Not Applicable

Recruiting

Conditions: Marijuana
HIV Infections

Interventions: Behavioral: Contingency Management - Cannabis

First Posted Date: 2021-04-29

Last Posted Date: 2025-02-24

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 45

Registration Number: NCT04866004

Locations: 🇺🇸
Center for Neurobehavioral Research on Addiction, Houston, Texas, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

Phase 2

Recruiting

Conditions: Glioblastoma

Interventions: Drug: Lomustine
Drug: Imipramine Hydrochloride

First Posted Date: 2021-04-28

Last Posted Date: 2024-08-09

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 25

Registration Number: NCT04863950

Locations: 🇺🇸
Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States

Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection

Phase 2

Completed

Conditions: SARS-CoV-2 Infection
Acute Kidney Injury

Interventions: Drug: Placebo
Drug: Nicotinamide riboside

First Posted Date: 2021-03-26

Last Posted Date: 2023-12-26

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 28

Registration Number: NCT04818216

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
University Health Systems, San Antonio, Texas, United States
🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

and more 1 locations

Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes
Glucose Metabolism Disorders (Including Diabetes Mellitus)
Energy Supply; Deficiency

Interventions: Other: Weight maintaining isocaloric ketogenic diet
Other: Standard weight maintaining diet
Dietary Supplement: Beta-hydroxy butyrate

First Posted Date: 2021-03-10

Last Posted Date: 2024-06-11

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 35

Registration Number: NCT04791787

Locations: 🇺🇸
University Health Systems-Texas Diabetes Institute, San Antonio, Texas, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

Host Immune Response to Novel RNA COVID-19 Vaccination

Completed

Conditions: COVID-19 Vaccine
Cancer

Interventions: Biological: COVID-19 Vaccine

First Posted Date: 2021-03-05

Last Posted Date: 2023-05-25

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 50

Registration Number: NCT04784689

Locations: 🇺🇸
Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States

Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution

Not Applicable

Completed

Conditions: Head and Neck Neoplasms

Interventions: Other: Software Solution for Radiation Therapy Treatment
Other: Radiation therapy

First Posted Date: 2021-03-04

Last Posted Date: 2023-01-25

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 21

Registration Number: NCT04782726

Locations: 🇺🇸
Mays Cancer Center, San Antonio, Texas, United States

Examining the Individual Response to a Restricted Sodium Diet in Hypertensive Patients

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: Modified Sodium Watcher Program + Digital Self-Monitoring
Behavioral: Usual care + Digital Self-Monitoring

First Posted Date: 2021-02-21

Last Posted Date: 2024-06-06

Lead Sponsor: The University of Texas Health Science Center at San Antonio

Target Recruit Count: 40

Registration Number: NCT04764253

Locations: 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy